Roche’s Avastin Fails to Add Time in Brain Cancer Survival Study

Roche’s Avastin Fails to Add Time in Brain Cancer Survival Study

Gianluca Colla/Bloomberg

The Roche Holding AG logo sits on a sign outside the company's headquarters in Basel, Switzerland.